EQH
Equitable Holdings, Inc.
EQH's outlook is improving, though it still trails on the overall score.
MS
Morgan Stanley
MS has a slight edge over EQH overall, supported by stronger modeled upside and stronger valuation.
EQH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
EQH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQH.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
EQH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.3x | $22.16 | -60% |
| Forward | 6.5x | $55.63 | — |
| Fair | 9.7x | $50.28 | -9.6% |
| Current | 11x | $55.63 | — |
| Expensive | 17x | $87.41 | +57% |
Historical ranges are pointers, not guarantees.
EQH's PE is in its fair range at 11x. If earnings grow as analysts expect, today's price would be 6.5x next year's earnings, in its cheap range.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over EQH in the historical PE scenario, which offers more potential upside but is not a forecast.
EQH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect EQH's earnings to grow and its profitability to improve, with its revenue holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over EQH on the outlook, with more favorable revenue expectations.
EQH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.49 | +63% |
| Q3 2026 | $5.20 | +$8.00 |
| Q2 2026 | -$3.32 | -377% |
| Q1 2026 | -$2.85 | -178% |
| Q4 2025 | -$4.83 | -228% |
| Q3 2025 | -$2.80 | -$1.81 |
| Q2 2025 | $1.20 | -52% |
| Q1 2025 | $3.64 | +9.3% |
| Q4 2024 | $3.78 | +8.6% |
EQH has returned to profit: it earned $5.20 per share over the past year, after losing money the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over EQH on earnings, with more consistent year-over-year improvement.
EQH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.9B | +168% |
| Q2 2026 | $1.7B | -30% |
| Q1 2026 | $4.2B | -7.6% |
| Q4 2025 | $3.3B | -9.5% |
| Q3 2025 | $1.5B | -53% |
| Q2 2025 | $2.4B | -33% |
| Q1 2025 | $4.6B | +105% |
| Q4 2024 | $3.6B | +67% |
EQH's revenue is recovering but still below its 2020 peak: $3.9B last quarter, up 168% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +129 points |
| Q2 2026 | -30% | -14 points |
| Q1 2026 | 21% | +17 points |
| Q4 2025 | 11% | -23 points |
| Q3 2025 | -93% | -93 points |
| Q2 2025 | -15% | -35 points |
| Q1 2025 | 3.8% | -7.3 points |
| Q4 2024 | 33% | +71 points |
EQH has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over EQH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
EQH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +342% |
| Q2 2026 | $643M | +89% |
| Q1 2026 | $499M | +216% |
| Q4 2025 | -$154M | -139% |
| Q3 2025 | $369M | -46% |
| Q2 2025 | $341M | -62% |
| Q1 2025 | $158M | +410% |
| Q4 2024 | $400M | +$792M |
EQH has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
EQH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -4.9M shares |
| 1 year | -7.7% | -22.8M shares |
| 3 years | -21% | -74.6M shares |
| 5 years | -34% | -141M shares |
| Available history | -45% | -220M shares |
EQH has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $238M |
| Q2 2026 | $366M |
| Q1 2026 | $147M |
| Q4 2025 | $277M |
| Q3 2025 | $676M |
| Q2 2025 | $235M |
| Q1 2025 | $262M |
| Q4 2024 | $260M |
EQH spent $1B buying back its own shares over the past year, down 28% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
EQH Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
EQH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 74.5 | Neutral |
EQH's weekly RSI is 66 (neutral) and its Stochastic is 75 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
EQH PE vs Financial Services Sector
| Metric | EQH | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 18% below |
| PE % | 57 | 63 | 6 pts below |
EQH has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
EQH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $53.4 | 4.1% above |
| 20 week MA | $51.4 | 8.1% above |
| 50 week MA | $46.4 | 20% above |
| 100 week MA | $48.8 | 14% above |
| 200 week MA | $41.4 | 34% above |
EQH has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
EQH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.6 | $25.1 | +2% |
| 2021 | $25.1 | $33.0 | +31% |
| 2022 | $33.0 | $28.6 | -13% |
| 2023 | $28.6 | $33.3 | +16% |
| 2024 | $33.3 | $47.5 | +43% |
| 2025 | $47.5 | $48.6 | +2.3% |
| 2026 YTD | $48.6 | $55.6 | +15% |
EQH has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.